transition from tirzepatide to retatrutide or Tirzepatide? Triple vs Dual Agonist Guide Retatrutide vs Tirzepatide: Mechanism, Trial

As people eat less junk food, major packaged-food companies are seeing the impact on sales and pivoting in an attempt to maintain consumer appetites.[1,2] Glucagon-like peptide-1 (GLP-1) receptor agonists were first approved in the United States in 2005 for the treatment of diabetes and in 2014 for weight loss.[3] Their cultural footprint expanded dramatically after semaglutide received approval for weight management in 2021.[3,4] Today, whether scrolling social media or chatting with friends, patients, or colleagues, its impossible not to notice the sweeping influence of Wegovy, Ozempic, and similar medications

Activating glucagon at the same time as GLP-1 and GIP appears to do two things in trials

PubMed , Cleveland Clinic , Accessed 19 Jan

antioxidant : tocopherol rich-extract E306